Immunomedics to Ring Opening Bell and Host R&D Day at the NASDAQ Stock ... Wall Street Journal We have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or "naked" form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins, ... |
